跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,053 条关于
“Bruton tyrosine kinase inhibitors”
全部
17,053
临床试验
8,238
药物
3,570
机构
57
资讯
5,188
2年前
Infection Risk With BTK Inhibitors Low, New CLL Study Finds
去年
Olverembatinib Shows Promise in TKI-Resistant CML and Ph+ ALL
9个月前
Tyrosine Kinase Inhibitors and Gene Therapies Show Promise for Wet AMD Treatment
2年前
Global CLL Trial Landscape Shows Robust Activity, Highlights Regional Disparities
去年
Real-World Data Validates Venetoclax's Efficacy in CLL Patients After BTK Inhibitor Treatment
2个月前
EGFR-TKIs Pose Highest Cardiovascular Risk Among Tyrosine Kinase Inhibitors, Meta-Analysis Finds
去年
Ruxolitinib Plus TKI Therapy Shows Promise in Chronic Myeloid Leukemia
上个月
Non-Tyrosine Kinase Inhibitors Market to Reach USD 18.7 Billion by 2036, Driven by Biomarker-Linked Oncology Approvals
去年
Study Reveals Superior Survival Outcomes for CLL and MCL Patients at Academic Cancer Centers
去年
BTK Inhibitors Challenge Traditional MS Coverage Models as Payers Seek Evidence-Based Alternatives to Step Therapy
第 1 页,共 519 页
上一页
下一页